← All trials
NCT06072586
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 18, 2023
- Primary completion
- May 31, 2025
- Completion date
- Oct 31, 2025
- First posted
- Oct 10, 2023
- Last posted
- Nov 28, 2023
- Enrollment
- 22
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of ArizonaLead sponsor
- Barrow Neurological InstituteCollaborator
- Ivy Brain Tumor CenterCollaborator
- Ivy Brain Tumor CenterOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.